Container
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
The variation in tonality in the drawings depicts a claimed contrasting appearance.
The broken line portion of the figure drawings is included to show unclaimed subject matter only and forms no part of the claimed design.
Claims
The ornamental design for a container, as shown and described.
D208828 | October 1967 | Braun |
3390809 | July 1968 | Becucci |
D245762 | September 13, 1977 | Takacs |
D292626 | November 3, 1987 | Chevassus |
D365206 | December 19, 1995 | Goodman |
D373952 | September 24, 1996 | Exarhos et al. |
D403176 | December 29, 1998 | Harper |
D406233 | March 2, 1999 | Kaplan |
D417077 | November 30, 1999 | Sheu |
D449165 | October 16, 2001 | van der Hulst |
D458127 | June 4, 2002 | de Groote |
D516801 | March 14, 2006 | Jones, III et al. |
D546173 | July 10, 2007 | Au |
D546671 | July 17, 2007 | Cronin et al. |
D549119 | August 21, 2007 | Becker |
D569103 | May 20, 2008 | Hoge et al. |
D623052 | September 7, 2010 | Giraud et al. |
D708940 | July 15, 2014 | Juna et al. |
D717161 | November 11, 2014 | Liu |
20090134209 | May 28, 2009 | Tonaltzin |
Type: Grant
Filed: Feb 5, 2014
Date of Patent: May 5, 2015
Assignee: Glaxo Group Limited (Brentford, Middlesex)
Inventors: Stuart John Farley (Ware), Andrew Michael Kelly (Letchworth)
Primary Examiner: Robert M Spear
Assistant Examiner: Keith Frank
Application Number: 29/481,356